Sylvain Choquet Selected Research

Lymphoproliferative Disorders (Lymphoproliferative Disorder)

11/2018	Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials.
10/2018	Cerebrospinal fluid interleukin (IL)-10 and IL-10:IL-6 ratio as biomarkers for small B-cell lymphoproliferations with leptomeningeal dissemination.
2/2017	Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.
6/2013	Fludarabine in Waldenstrom's macroglobulinemia.
4/2013	Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.
2/2012	Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
12/2007	Salvage therapy for relapsed posttransplant lymphoproliferative disorders (PTLD) with a second progression of PTLD after Upfront chemotherapy: the role of single-agent rituximab.
8/2007	Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.
2/2007	CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation.
4/2006	Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvain Choquet Research Topics

Disease

26	Lymphoma (Lymphomas) 11/2022 - 08/2011
13	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2018 - 01/2002
12	Neoplasms (Cancer) 01/2022 - 01/2002
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2022 - 09/2011
7	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2016 - 04/2003
6	Multiple Myeloma 09/2021 - 10/2007
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 02/2011
3	B-Cell Lymphoma (Lymphoma, B Cell) 10/2022 - 10/2012
3	COVID-19 01/2022 - 01/2021
3	Infections 09/2021 - 06/2015
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 09/2004
3	Neutropenia 01/2020 - 07/2003
3	Hematologic Neoplasms (Hematological Malignancy) 12/2019 - 07/2018
2	Glioma (Gliomas) 01/2021 - 04/2020
2	Disease Progression 07/2020 - 02/2012
2	Sudden Infant Death (SID) 12/2019 - 07/2018
2	Plasma Cell Leukemia 01/2016 - 10/2008
2	Paraproteinemias (Monoclonal Gammopathy) 03/2013 - 06/2010
2	POEMS Syndrome (Syndrome, POEMS) 03/2013 - 06/2010
2	Hodgkin Disease (Hodgkin's Disease) 01/2013 - 09/2004
2	Intraocular Lymphoma 11/2012 - 05/2008
2	Skin Manifestations 06/2010 - 07/2003
1	Macrophage Activation Syndrome 10/2022
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 08/2022
1	Photosensitivity Disorders (Photodermatitis) 02/2022
1	Melanoma (Melanoma, Malignant) 10/2021
1	Skin Neoplasms (Skin Cancer) 10/2021
1	Seizures (Absence Seizure) 06/2021
1	Coma (Comas) 06/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Diarrhea 01/2020
1	Fatigue 01/2020
1	Hyponatremia 01/2020
1	Nausea 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Vomiting 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Epstein-Barr Virus Infections 01/2019

Drug/Important Bio-Agent (IBA)

11	Rituximab (Mabthera)FDA Link 01/2019 - 04/2006
10	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 05/2008
9	selinexorIBA 02/2022 - 01/2019
7	Dexamethasone (Maxidex)FDA LinkGeneric 09/2021 - 10/2007
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2017 - 11/2012
5	fludarabineIBA 01/2016 - 04/2003
4	Biological ProductsIBA 10/2020 - 02/2011
3	Monoclonal AntibodiesIBA 01/2022 - 01/2013
3	Immunoglobulins (Immunoglobulin)IBA 12/2019 - 05/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 06/2010
3	Procarbazine (Matulane)FDA Link 06/2017 - 01/2012
3	Vincristine (Oncovin)FDA LinkGeneric 06/2017 - 06/2015
3	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2017 - 11/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2017 - 10/2008
3	Alkylating AgentsIBA 01/2016 - 01/2013
3	purineIBA 01/2016 - 01/2013
3	Lenalidomide (CC 5013)FDA Link 11/2015 - 03/2013
3	Methylprednisolone FDA LinkGeneric 01/2013 - 11/2011
2	Pharmaceutical PreparationsIBA 10/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2011
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 06/2015
2	Interleukin-10 (Interleukin 10)IBA 10/2018 - 01/2016
2	InterleukinsIBA 10/2018 - 01/2016
2	Bortezomib (Velcade)FDA Link 01/2016 - 10/2008
1	TOR Serine-Threonine KinasesIBA 10/2021
1	PENTAIBA 09/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Bendamustine Hydrochloride FDA Link 10/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2020
1	Retinaldehyde (Retinal)IBA 06/2020
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 04/2020
1	Amino Acids FDA Link 04/2020
1	bismuth subsalicylate (Pepto-bismol)FDA LinkGeneric 01/2020
1	Olanzapine (Zyprexa)FDA Link 01/2020
1	Exportin 1 ProteinIBA 01/2020
1	CannabinoidsIBA 01/2020
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2020
1	Loperamide (Imodium)FDA LinkGeneric 01/2020
1	MegestrolIBA 01/2020
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2020
1	SodiumIBA 01/2020
1	Thrombopoietin ReceptorsIBA 01/2020
1	Serotonin 5-HT3 Receptor AntagonistsIBA 01/2020
1	Neurokinin-1 Receptor AntagonistsIBA 01/2020
1	OctagamIBA 12/2019
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2019

Therapy/Procedure

21	Therapeutics 10/2022 - 07/2003
20	Drug Therapy (Chemotherapy) 08/2022 - 01/2002
7	Stem Cell Transplantation 11/2022 - 02/2014
6	Transplantation 02/2014 - 04/2004
4	Radiotherapy 11/2022 - 08/2011
4	Organ Transplantation 08/2007 - 01/2002
3	Salvage Therapy 01/2015 - 12/2007
3	Hematopoietic Stem Cell Transplantation 02/2011 - 09/2004
2	Immunotherapy 01/2022 - 01/2021
2	Artificial Respiration (Mechanical Ventilation) 09/2021 - 06/2021
2	Kidney Transplantation 01/2019 - 04/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2022
1	Photopheresis 02/2022
1	Renal Dialysis (Hemodialysis) 08/2021
1	Length of Stay 01/2021
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2020